pharmaceutical research

CureLauncher To Boost Fundriaising, Study Participation For Early Stage PharmaMany American medical innovations, including possible new drugs and medical devices, can’t raise the money needed for early stage testing. Now there is a way for every affected person to help those dedicated scientists receive the funds needed to make the next medical breakthrough.
Synthetic Biologics Launches Free Investor Relations Mobile ApplicationSynthetic Biologics Inc. (NYSE Amex: SYN) Thursday announced the release of its investor relations mobile iPhone App, called the "SYN IR" App, now available for free at the Apple App Store on the iPhone or iPad or at
GeneGo's ToxHunter Suite Now Available